Themes for Innovation

Infection

Despite remarkable advances in public health, infectious diseases continue to pose an increasing global challenge through newly (re)emerging infectious agents, escalating antimicrobial drug resistance, and limitations in effectiveness and accessibility of crucial vaccines and therapies in low- and middle-income countries. The LUMC Research Innovation Theme Infection focuses on groundbreaking research initiatives and preparedness programs to face the challenges ahead.

Mission & vision

Our mission

LUMC Theme Infection supports, inspires, and unites researchers working in the field of infection in LUMC and beyond. Our Theme is built on a strong community of biomedical scientists and clinicians, who dissect host-pathogen interactions to develop out-of-the-box prevention strategies and cures for the most pressing infectious disease challenges.

Special consideration is given to vulnerable populations, such as children, the elderly, and immunocompromised persons. As infections do not stop at borders, we work together with people around the world.

…

Our mission

LUMC Theme Infection supports, inspires, and unites researchers working in the field of infection in LUMC and beyond. Our Theme is built on a strong community of biomedical scientists and clinicians, who dissect host-pathogen interactions to develop out-of-the-box prevention strategies and cures for the most pressing infectious disease challenges.

Special consideration is given to vulnerable populations, such as children, the elderly, and immunocompromised persons. As infections do not stop at borders, we work together with people around the world.

Our vision

LUMC Theme Infection aims to be an inspirational leader in the development of knowledge-driven strategies to combat infectious diseases through the development of novel diagnostics, epidemiological models, vaccines, drugs, and immune modulators. We strive for a world where infectious diseases are no longer a threat to global health.

Our expertise

Theme Infection brings together leading researchers and clinicians to tackle the world’s most urgent infectious disease challenges. Our expertise spans the full spectrum from fundamental discovery to clinical application, including vaccine and drug development, diagnostics for emerging and poverty-related diseases, infection immunology, antimicrobial resistance (AMR), microbiome research, epidemiology, and data science. Using advanced technologies such as single-cell and multi-omics analyses, artificial intelligence, and controlled human infection models, we translate scientific insights into innovative solutions. Through global collaborations, we improve prevention, diagnosis, and treatment of infectious diseases worldwide.

Collaborations

In addition to LUMC departments, Theme Infection has strong connections with other faculties of Leiden University, the Leiden Bioscience Park, and beyond. Like:

  • Collaborations with InFECT-NL
  • Collaborations with field sites and academic centers in Bangladesh, Brazil, Gabon, Indonesia, Uganda, South-Africa and more

Our research facilities

Infection researchers frequently use the state-of-the-art LUMC research facilities. These are the facilities that our researchers use the most.

Internships

Theme Infection organizes courses which are part of the bachelor’s and master’s programs of Biomedical Sciences and Medicine at the Leiden University Medical Center. Theme Infection also offers national and international courses, workshops, and trainings.

There are frequent opportunities for students to undertake shorter or longer research projects in the field of infectious diseases within the LUMC. Please contact us via infection@lumc.nl and describe your background and interests.

Contact

Email:Infection@lumc.nl 

Management team

  • Simon Jochems, associate professor and head of the Mucosal and Systems Immunology group
  • Jutte de Vries, associate professor in Clinical Virology and head of the Clinical Viral Metagenomics group
  • Willianne Hoepel, junior group leader focusing on antibody glycosylation in context of respiratory infections